A

lzheimer’s disease is often broadly referred to as “Type 3 diabetes,” because it’s thought that glucose processing goes haywire in the neurodegenerative disease, just as it does in diabetes.

A new National Institutes of Health study adds some credence to that theory, finding that glitches in the way the brain breaks down glucose — a process called glycolysis — seem to correspond with more severe symptoms in patients with Alzheimer’s.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Reply to Aseni Cancel reply

Please enter your name.
Please enter a comment.

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.